AIDS Therapies
U.S. Patent Office Invalidates Patent for 3TC/Epivir
Published in AIDS Weekly, January 15th, 2001
The decision is the latest in a series of rulings around the world upholding BioChem's patent rights for 3TC/Epivir in patent disputes between BioChem and Emory University. Patent offices in Europe, Japan, Australia and Norway reviewed BioChem and Emory University's filings and universally decided in BioChem's favor.
The U.S. Patent Office ruled that Emory was not entitled to its patent. Emory's patent was granted five years after...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
Source: AIDS Weekly (2001-01-15)
More Articles from AIDS Weekly
- Co-Infection (HCV/HIV)
Tailor-Made Interferon Treatments Fail - Pharmacoeconomics
Non-Protease Inhibitor Scores High on Cost-Effectiveness Test - Immunology
Study of HIV Patients Identifies Key Factor in Controlling T Cells - Myocardial Dysfunction
Potential Mechanism Revealed - Pathogenesis
Macrophages May Play More Important Role in HIV Infection than Previously Thought - AIDS Therapies
Follow-Up Report of Theft of AIDS Drug Suggests a Business Dispute - More from this issue of AIDS Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
